发明名称 |
COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES |
摘要 |
The technology relates generally to the field of immunology and relates in part to methods for activating T cells and other cells resulting in an immune response against a target antigen. The technology also relates to costimulation of therapeutic cells that express chimeric antigen receptors that recognize target antigens using chimeric MyD88- and CD40-derived polypeptides. The technology further relates in part to therapeutic cells that express chimeric antigen receptors, wherein the chimeric antigen receptors have an endodomain that includes MyD88- and CD40-derived polypeptides, and methods for treating patients using the modified therapeutic cells. |
申请公布号 |
US2016058857(A1) |
申请公布日期 |
2016.03.03 |
申请号 |
US201514842710 |
申请日期 |
2015.09.01 |
申请人 |
BELLICUM PHARMACEUTICALS, INC. |
发明人 |
Spencer David;Foster Aaron Edward;Slawin Kevin |
分类号 |
A61K39/00;C12N9/90;C12N9/64;C07K14/47;C07K14/705 |
主分类号 |
A61K39/00 |
代理机构 |
|
代理人 |
|
主权项 |
1. A nucleic acid comprising a promoter operably linked to a polynucleotide encoding a chimeric stimulating molecule, wherein the chimeric stimulating molecule comprises
(i) a MyD88 polypeptide or a truncated MyD88 polypeptide lacking the TIR domain; (ii) a CD40 cytoplasmic polypeptide region lacking the CD40 extracellular domain; and (iii) a membrane targeting region. |
地址 |
Houston TX US |